DNA Methylation in the Pathogenesis of Systemic Lupus Erythematosus

Publisher： Bentham Science Publishers

E-ISSN： 1875-6204|3|1|73-78

ISSN： 1570-1603

Source： Current Pharmacogenomics, Vol.3, Iss.1, 2005-03, pp. : 73-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Insight on the Pathogenesis and Treatment of Systemic Lupus Erythematosus

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 18, Iss. 2, 2018-02 ,pp. : 110-123

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacotherapy of systemic lupus erythematosus

By Francis Lisa   Perl Andras  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 9, 2009-06 ,pp. : 1481-1494

Informa Healthcare

Access to resources Recommend Favorite

Belimumab: In Systemic Lupus Erythematosus

By Burness Celeste B.   McCormack Paul L.  

Drugs, Vol. 71, Iss. 18, 2011-12 ,pp. : 2435-2444

Adis International

Access to resources Recommend Favorite

Neuropsychiatric Systemic Lupus Erythematosus

By  

Current Neuropharmacology, Vol. 9, Iss. 3, 2011-09 ,pp. : 449-457

Bentham Science Publishers

Access to resources Recommend Favorite

Epstein–Barr virus and autoimmunity: the role of a latent viral infection in multiple sclerosis and systemic lupus erythematosus pathogenesis

By Casiraghi Costanza   Horwitz Marc S  

Future Virology, Vol. 8, Iss. 2, 2013-02 ,pp. : 173-182

Future Medicine

Access to resources Recommend Favorite